Covid-19 vaccinations, self-reported health, and worldviews – A representative survey from Germany

Main Article Content

Harald Walach Rainer Johannes Klement

Abstract

The novel modRNA vaccinations against Covid-19 were hailed as an immense progress, but indications for severe side effects were noted. We wanted to know to what extent people report having had diseases during the last two years that are associated with Covid-19 vaccinations, and whether there is a difference between those vaccinated and those without vaccinations. We also wanted to know whether the willingness to be vaccinated is associated with particular worldviews.


We therefore conducted a representative internet survey, organized by Debaro GmbH, Munich, a professional survey company. The final sample was prepared to yield an approximately representative sample of the German population. Altogether 1051 responses were analyzed. Vaccinated persons reported significantly more events that required the visit of a doctor (42% versus 30%, p = 0.0024), more Covid-19 infections (30% vs. 23%, p = 0.0535) and more musculoskeletal problems (21% vs. 15%, p = 0.059). Vaccinated respondents reported significantly more diseases overall (mean 1.6±1.6 vs. 1.3±1.4; p = 0.0023). We analyzed the likelihood to be vaccinated by a logistic regression model. The vaccinated were more likely to be older, have German nationality, to have higher income, to live alone, to have been taking more medications and to know someone who died of Covid-19 but no one who might have died after Covid-19 vaccination. Further, a materialist worldview was positively associated with the probability of getting vaccinated, while the belief that there are other realms of reality more important than everyday reality and that these realms are beyond any scientific explanation was negatively related. In addition, the belief that mRNA vaccinations help humankind was a highly significant predictor of the probability to be vaccinated. Finally, a propensity score analysis accounting for sociodemographic variables and pre-vaccination health status confirmed that Covid-19 occurred more frequently in vaccinated individuals (31% vs. 23%, p=0.103). Again, the belief that mRNA-based vaccines are beneficial to humanity was significantly more present among the propensity-score matched vaccinated compared to the unvaccinated group (agreed/disagreed/uncertain: 34.6%/30.8%/34.6% versus 22.9%/45.2%/31.9%, p=0.0075).


This self-report survey supports the view that the Covid-19 vaccinations have produced some side-effects that need to be further investigated, preferably by hard data from insurance companies or similar organizations.

Article Details

How to Cite
WALACH, Harald; KLEMENT, Rainer Johannes. Covid-19 vaccinations, self-reported health, and worldviews – A representative survey from Germany. Medical Research Archives, [S.l.], v. 12, n. 12, dec. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6205>. Date accessed: 06 jan. 2025. doi: https://doi.org/10.18103/mra.v12i12.6205.
Section
Research Articles

References

1. Kheriaty A. The New Abnormal: The Rise of the Biomedical Security State. Washington: Regnery; 2022.
2. Doshi P. Covid-19 vaccines: In the rush for regulatory approval, do we need more data? BMJ. 2021;373:n1244.
3. Fraiman J, Erviti J, Jones M, et al. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022;40(40):5798-5805.
4. Tanveer S, Rowhani-Farid A, Hong K, Jefferson T, Doshi P. Transparency of COVID-19 vaccine trials: decisions without data. BMJ Evidence-Based Medicine. 2021:bmjebm-2021-111735.
5. Seneff S, Nigh G, Kyriakopoulos A, McCullough P. innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes and microRNAs. Food and Chemical Toxicology. 2022;164:113008.
6. Rose J. A report on the U.S. vaccine adverse events reporting system (VAERS) on the Covid-19 messenger ribonucleic acid (mRNA) biologicals. Science, Public Health Policy, and the Law. 2021;2:59-80.
7. Walach H, Klement RJ, Aukema W. The risk-benefit ratio of Covid-19 vaccines: Publication policy by retraction does nothing to improve it. Clinical and Translational Discovery. 2022;2(1):e35.
8. Walach H, Klement RJ, Aukema W. The Safety of COVID-19 vaccinations — Should we rethink the policy? Science, Public Health Policy, and the Law. 2021;3:87-99.
9. Chui CSL, Fan M, Wan EYF, et al. Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study. eClinicalMedicine. 2022;50:101504.
10. Hulscher N, Hodkinson R, Makis W, McCullough PA. Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Failure. 2024;n/a(n/a).
11. Buergin N, Lopez-Ayala P, Hirsiger JR, et al. Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 Booster Vaccination. European Journal of Heart Failure. 2023;25:1871-1881.
12. Mentzer D, Oberle D, Sreit R, Weisser K, Keller-Stanislawski B. Sicherheitsprofil der COVID-19-Impfstoffe - Sachstand 31.3.2023. Bulletin für Arzneimittelsicherheit. 2023;2:12-29.
13. Rolfs N, Huber C, Schwarzkopf E, et al. Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non–vaccine-associated myocarditis within the prospective multicenter registry—“MYKKE”. American Heart Journal. 2024;267:101-115.
14. Faksova K, Walsh D, Jiang Y, et al. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024;in press.
15. Talib N, Fronza M, Marschner CA, Thavendiranathan P, Karur GR, Hanneman K. Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination. Journal of Cardiovascular Magnetic Resonance. 2024;26(1):101036.
16. Klement RJ, Walach H. Commentary: raised c-troponin levels as a sign of myocardial injury after COVID-19 vaccination in healthy individuals are worrying. The Egyptian Heart Journal. 2024;76(1):16.
17. Mead MN, Seneff S, Wolfinger R, et al. COVID-19 mRNA vaccines: lessons learned from the registrational trials and Global vaccination campaign. Cureus. 2024;16(1):e52876.
18. Sukura K. Big data analysis suggests COVID vaccination increases excess mortality of highly vaccinated north temperate zone and north frigid zone countries. OSF Preprints. 2024.
19. Lataster R. Should we now discuss possible COVID-19 vaccine negative effectiveness? (Letter). Australian Journal for General Practitioners. 2024;53:423-428.
20. Kim HJ, Kim M-H, Choi MG, Chun EM. Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea. Molecular Psychiatry. 2024;29(11):3635-3643.
21. Kuhbandner C, Reitzner M. Estimation of Excess mortality in Germany during 2020-2022. Cureus. 2023;15(5):e39371.
22. Desmet M. The Psychology of Totalitarianism. London & White River Junction VT: Chelso Green; 2022.
23. Walach H, Ofner M, Ruof V, Herbig M, Klement RJ. Why do people consent to receiving SARS-CoV2 vaccinations? A Representative Survey in Germany. BMJ Open. 2022;12(8):e060555.
24. Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL. Psychedelics alter metaphysical beliefs. Scientific Reports. 2021;11(1):22166.
25. Tibshirani R. Regression shrinkage and selection via the Lasso. Journal of the Royal Statistical Society B. 1996;58:267-288.
26. Zhao Q-Y, Luo J-C, Su Y, Zhang Y-J, Tu G-W, Luo Z. Propensity score matching with R: conventional methods and new features. Annals of Translational Medicine. 2021;9(9):812.
27. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236-1238.
28. McKelvey RD, Zavoina W. A statistical model for the analysis of ordinal level dependent variables. Journal of the Mathematical Society. 1975;4:103-120.
29. Yahi N, Chahinian H, Fantini J. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? Journal of Infection. 2021.
30. Federico M. The immunologic downsides associated with the powerful translation of current COVID-19 vaccine mRNA can be overcome by mucosal vaccines. vaccines. 2024;12(11):1281.
31. Ioannidis JPA. The infection fatality rate of COVID-19 inferred from seroprevalence data. Bulletin of the World Health Organization. 2021;99:19-33F.
32. Kwan AC, Ebinger JE, Wei J, et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. Nature Cardiovascular Research. 2022;1(12):1187-1194.
33. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine. 2021;385(23):2140-2149.
34. Klement RJ, Walach H. SEIR models in the light of Critical Realism - a critique of exaggerated claims about the effectiveness of Covid 19 vaccinations. Futures. 2023:103119.